Enhanced antithrombotic effect of warfarin associated with low-dose alcohol consumption

Pharmacotherapy

Volumn 25, Issue 2, 2005, Pages 303-307

  Havrda, Dawn E ^a   Mai, Tien ^b   Chonlahan, Jennifer ^b  

^a SHENANDOAH UNIVERSITY   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

Alcohol; Anticoagulation; Ethanol; Ethyl alcohol; INR; International normalized ratio; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ATORVASTATIN; CYTOCHROME P450; GEMFIBROZIL; GLYCERYL TRINITRATE; IPRATROPIUM BROMIDE; ISOSORBIDE DINITRATE; LEVOTHYROXINE; METOPROLOL; ROSIGLITAZONE; WARFARIN;

ADULT; ALCOHOL CONSUMPTION; ANTICOAGULATION; ARTICLE; BEER; CASE REPORT; CAUCASIAN; CEREBROVASCULAR ACCIDENT; DRUG ALCOHOL INTERACTION; DRUG METABOLISM; HEART PROTECTION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LONG TERM CARE; MALE; PROTEIN BINDING;

ALCOHOL DRINKING; ANTICOAGULANTS; BLOOD COAGULATION; CEREBROVASCULAR ACCIDENT; DRUG INTERACTIONS; ETHANOL; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; WARFARIN;

EID: 13644260557     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.25.2.303.56955     Document Type: Article

References (20)

1. Hirsh J, Fuster V, Ansell J, Halperin JL. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. Circulation 2003;107:1692-711.
2. O'Reilly R. Lack of effect of mealtime wine on the hypoprothrombinemia of oral anticoagulants. Am J Med Sci 1979;277:189-94.
3. O'Reilly R. Lack of effect of fortified wine ingested during fasting and anticoagulant therapy. Arch Intern Med 1981;141:458-9.
4. Karlson B, Leijd B, Hellstrom K. On the influence of vitamin K-rich vegetables and wine on the effectiveness of warfarin treatment. Acta Med Scand 1986;220:347-50.
5. Di Castelnuovo A, Rotondo S, lacoviello L, Donati MB, de Gaetano G. Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation 2002;105:2836-44.
6. Grønbæk M, Becker U, Johansen D, et al. Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer. Ann Intern Med 2000;133:411-19.
7. Shaper AG, Wannamethee SG. Alcohol intake and mortality in middle aged men with diagnosed coronary heart disease. Heart 2000;83:394-9.
8. Weathermon R, Crabb DW. Alcohol and medication interactions. Alcohol Res Health 1999;23:40-54.
9. Sellers EM, Holloway MR. Drug kinetics and alcohol ingestion. Clin Pharmacokinet 1978;3:440-52.
10. Hankin L. Beer alcohol and calories. Available from www.brewery.org/ brewery/library/AlClbinger.html. Accessed July 26, 2004.
11. Cleave Books. Calculator for %AbV and equivalent values. Available from www.ex.ac.uk/trol/scol/ccalcoh4.htm. Accessed July 26, 2004.
12. Leur J, Patterson LE. Warfarin. In: Abate MA, Abel SR, eds. DrugDex drug evaluation monographs, vol 118. Greenwood Village, CO: Micromedex, Inc., 2004.
13. Cropp JS, Bussey HI. A review of enzyme induction of warfarin metabolism with recommendations for patient management. Pharmacotherapy 1997;17:917-28.
14. Milligan SR, Kalita JC, Pocock V, et al. The endocrine activities of 8-prenylnaringenin and related hop (Humulus lupulus L.) flavonoids. J Clin Endocrinol Metab 2000;85:4912-15.
15. Hodek P, Trefil P, Stiborova M. Flavonoids - potent and versatile biologically active compounds interacting with cytochromes P450. Chem Biol Interact 2001;139:1-21.
16. Anonymous. Hops. In: Fetrow CW, Avila JR, eds. Professional's handbook of complementary and alternative medicines, 3rd ed. Springhouse: Lippincott Williams & Wilkins, 2004:425-8.
17. Bristol-Myers Squibb Company. Coumadin (warfarin) package insert. Princeton, NJ; 2002.
18. Wen X, Wang JS, Backman JT, Kivistö KT, Neuvonen PJ. Gemfibrozil is a potent inhibitor of human cytochrome P450 2C9. Drug Metab Dispos 2001;29:1359-61.
19. Parke-Davis Division of Pfizer Inc. Lipitor (atorvastatin) package insert. Dublin, Ireland; 2004.
20. Wells PS, Holbrook AM, Crowther NR, Hirsh J. Interactions of warfarin with drugs and food. Ann Intern Med 1994;121:676-83.